Key result
In older adults with obesity, higher log-transformed hs-CRP was significantly associated with depressive symptoms (OR 2.17, P=0.001).
Why the study?
To test the hypothesis that depressive symptoms vary with high-sensitivity C-reactive protein among older adults with obesity.
Cross-Sectional (n=148)
Odds Ratio: 2.17
p-value: p=0.001
In older adults with obesity, higher hs-CRP and male sex are associated with depressive symptoms, suggesting hs-CRP may serve as a biomarker for depression in this population.
May flag at-risk obese older adults; leaves open causality and clinical utility pending prospective validation.
Objectives To test the hypothesis that depressive symptoms vary with high-sensitivity C-reactive protein (hs-CRP), among older adults with obesity. Methods This was a cross-sectional, secondary analysis of baseline data from two related lifestyle intervention trials. The study sample comprises 148 consecutively recruited, community-dwelling older adults (age >=65 years) without severe psychiatric illness and with body mass index >=30 kg/m 2 . Logarithmically transformed GDS was analyzed as the dependent variable. Independent variables included log-transformed hs-CRP and covariates: sex, age, and concurrent use of antidepressant medication at baseline. An additional analysis was performed using binary conversion of the GDS scores, wherein a cutoff score of 5 was considered positive for depressive symptoms. Results Sample mean GDS score was 2.7 (SD 3.0, range 0 – 14). A significant multivariate model of GDS scores (R 2 = .089, F = 3.5, P = .010) revealed log-transformed hs-CRP ( P = .017) and male sex ( P = .012) as associated with depressive symptoms. Supplemental analysis demonstrated associations between depressive symptoms and log-transformed hs-CRP (OR 2.17, P = .001) and between depressive symptoms and male sex (OR 3.78, P = .013). Univariate logistic regression found hs-CRP to be associated with depressive symptoms. Conclusions In older adults with obese BMI, male sex and higher hs-CRP are associated with depression, even in a group with relatively minimal depressive symptoms. Hs-CRP may offer clinical utility as a biomarker for depression among older adults with obese BMI, even among those with non-severe psychiatric symptomatology.
No takes yet. Share an insight, caveat, or question.
Heisey et al. (2023) conducted a cross-sectional in Obesity and depressive symptoms (n=148). High-sensitivity C-reactive protein (hs-CRP) was evaluated on Depressive symptoms (Geriatric Depression Scale scores) (OR 2.17, p=0.001). In older adults with obesity, higher log-transformed hs-CRP was significantly associated with depressive symptoms (OR 2.17, P=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: